Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wen Ding

Showing results (411-420 of 479) with videos related to

Pageof 48
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|September 3, 2013
B-cell Lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese populationQiong Li, Jun Yin, Xu Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2014
A novel platform for engineering blood-brain barrier-crossing bispecific biologicsGraham K Farrington, Nadia Caram-Salas, Arsalan S Haqqani, et al.
Advanced Healthcare Materials|February 17, 2026
Golgi Apparatus-Targeting Immunostimulant for Synergistic Activation of Antitumor Immunity via Pyroptosis Induction and PD-L1 DegradationRong-Rong Zheng, Qiu-Yuan Li, Shui-Ying Zhang, et al.
Cancer Science|September 17, 2022
Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinomaChun Yang, Xiao-Wen Cui, Zhi-Wen Ding, et al.
Cancer Research|September 28, 2017
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal CarcinomaJiang Yuan, Yan-Yi Jiang, Anand Mayakonda, et al.
ACS Applied Materials & Interfaces|September 25, 2025
Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 UpregulationYi Cen, Xin-Xuan Li, Ying Chen, et al.
Scientific Reports|August 31, 2017
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Journal of the American Medical Informatics Association : JAMIA|March 28, 2015
A novel tool for visualizing chronic kidney disease associated polymorbidity: a 13-year cohort study in TaiwanChih-Wei Huang, Shabbir Syed-Abdul, Wen-Shan Jian, et al.
Molecular Oncology|February 1, 2015
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancerWenwen Chien, Qiao-Yang Sun, Kian Leong Lee, et al.
Acta Pharmacologica Sinica|April 12, 2024
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinomaQi-Yi Zhang, Wen Ding, Jian-Shan Mo, et al.
Pageof 48

Showing results (411-420 of 479) with videos related to

Sort By:
Pageof 48
Asian Pacific Journal of Cancer Prevention : APJCP|September 3, 2013
B-cell Lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of gastric cardiac adenocarcinoma in a Chinese populationQiong Li, Jun Yin, Xu Wang, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 30, 2014
A novel platform for engineering blood-brain barrier-crossing bispecific biologicsGraham K Farrington, Nadia Caram-Salas, Arsalan S Haqqani, et al.
Advanced Healthcare Materials|February 17, 2026
Golgi Apparatus-Targeting Immunostimulant for Synergistic Activation of Antitumor Immunity via Pyroptosis Induction and PD-L1 DegradationRong-Rong Zheng, Qiu-Yuan Li, Shui-Ying Zhang, et al.
Cancer Science|September 17, 2022
Gankyrin and TIGAR cooperatively accelerate glucose metabolism toward the PPP and TCA cycle in hepatocellular carcinomaChun Yang, Xiao-Wen Cui, Zhi-Wen Ding, et al.
Cancer Research|September 28, 2017
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal CarcinomaJiang Yuan, Yan-Yi Jiang, Anand Mayakonda, et al.
ACS Applied Materials & Interfaces|September 25, 2025
Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 UpregulationYi Cen, Xin-Xuan Li, Ying Chen, et al.
Scientific Reports|August 31, 2017
Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicinManoj Garg, Deepika Kanojia, Anand Mayakonda, et al.
Journal of the American Medical Informatics Association : JAMIA|March 28, 2015
A novel tool for visualizing chronic kidney disease associated polymorbidity: a 13-year cohort study in TaiwanChih-Wei Huang, Shabbir Syed-Abdul, Wen-Shan Jian, et al.
Molecular Oncology|February 1, 2015
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancerWenwen Chien, Qiao-Yang Sun, Kian Leong Lee, et al.
Acta Pharmacologica Sinica|April 12, 2024
Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinomaQi-Yi Zhang, Wen Ding, Jian-Shan Mo, et al.
Pageof 48